| RS1602349137 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1602349143 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease |
| RS1602349166 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS1602349183 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1602349248 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349264 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1602349280 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebellar ataxia, Charcot-Marie-Tooth Neuropathy X |
| RS1602349293 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349302 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease |
| RS1602349316 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease |
| RS1602349322 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS1602349341 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS1602349369 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349383 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1602349388 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349420 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349446 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1602349451 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1602349468 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349535 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349572 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349591 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1602349603 |
GJB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349628 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease |
| RS1602349641 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS1602349655 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1602349692 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349705 |
RP2
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1602349716 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease |
| RS1602349730 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1602349779 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349785 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1602349940 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1602349955 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602349962 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602350003 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602350012 |
GJB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS1602350029 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602350059 |
GJB1
|
Health Risk |
Pathogenic |
— |
| RS1602350062 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1602354302 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602354996 |
RP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 3, Retinal dystrophy |
| RS1602355025 |
RP2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS1602360475 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602363343 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602363550 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602369798 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602373055 |
PLP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS1602379828 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, Wieacker-Wolff syndrome |
| RS1602382354 |
ZC4H2
|
Health Risk |
Pathogenic |
— |
| RS1602382829 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1602382987 |
PLP1;RAB9B
|
Health Risk |
Likely pathogenic |
— |
| RS1602383021 |
PLP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 2, Pelizaeus-Merzbacher disease |
| RS1602383045 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS1602383261 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1602383268 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1602384101 |
PLP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS1602384238 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1602385663 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1602385672 |
PLP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS1602385699 |
PLP1
|
Health Risk |
Likely pathogenic |
— |
| RS1602385860 |
NONO
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 34, Syndromic X-linked intellectual disability 34 |
| RS1602386427 |
NONO
|
Health Risk |
Pathogenic |
— |
| RS1602386709 |
CASK
|
Health Risk |
Pathogenic |
FG syndrome 4, Syndromic X-linked intellectual disability Najm type |
| RS1602387702 |
NONO
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 34, Inborn genetic diseases |
| RS1602395717 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602398950 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS16024 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1602402229 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602402258 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602402549 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602404847 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1602405079 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Thyroid cancer |
| RS1602405176 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602405239 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602405293 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602405375 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602405588 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1602407457 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1602409174 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS1602409271 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1602410098 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1602410239 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1602410858 |
TBX22
|
Health Risk |
Pathogenic |
Cleft palate with ankyloglossia, Cleft palate with ankyloglossia |
| RS1602410916 |
TBX22
|
Health Risk |
Pathogenic |
Cleft palate with ankyloglossia, Cleft palate with ankyloglossia |
| RS1602411514 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602411858 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1602411954 |
TBX22
|
Health Risk |
Pathogenic |
Cleft palate with ankyloglossia, Cleft palate with ankyloglossia |
| RS1602412679 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1602413408 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1602413491 |
TBC1D8B
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 20 |
| RS1602413582 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1602414282 |
TBX22
|
Health Risk |
Pathogenic |
Cleft palate with or without ankyloglossia, X-linked |
| RS1602416457 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602417503 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Thyroid cancer |
| RS1602418853 |
SMC1A
|
Health Risk |
Likely pathogenic |
— |
| RS1602424764 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS1602424843 |
CASK
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic X-linked intellectual disability Najm type, FG syndrome 4 |
| RS1602424869 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS1602426573 |
HSD17B10
|
Health Risk |
Likely pathogenic |
HSD10 mitochondrial disease, HSD10 mitochondrial disease |